MICHELLE DIXON: Open Payments
NPI 1831754787 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 18 payments from 11 companies in 2025. Trend: 2023 $1,000 · 2024 $807 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $164 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $29 |
| AKEBIA THERAPEUTICS INC | 1 | $29 |
| Travere Therapeutics, Inc. | 1 | $25 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: KRYSTEXXA, JYNARQUE, ACTHAR, Veltassa, Vafseo, TARPEYO, JARDIANCE, TAVNEOS.
Industry payments across NY — which companies pay providers there.
